Evidence map›Paper›PMID 30485545›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2019

Understanding the role of genetic variability in LRRK2 in Indian population.

Asha Kishore, Ashwin Ashok Kumar Sreelatha, Marc Sturm, Felix von-Zweydorf, Lasse Pihlstrøm, Francesco Raimondi, Rob Russell, Peter Lichtner, Moinak Banerjee, Syam Krishnan and 11 more

Open access · greenAbstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Genetic Sketch of Parkinson's Disease in India.Annals of Indian Academy of Neurology · 2025
    Article
  4. Article
  5. Review
  6. Functional Analyses of Two Novel LRRK2 Pathogenic Variants in Familial Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2022
    Article
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 6 countries.

Asha KishoreSree Chitra Tirunal Institute for Medical Science and Technology, Kerala, India.
Ashwin Ashok Kumar SreelathaCentre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany.
Marc SturmInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Felix von-ZweydorfGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Lasse PihlstrømDepartment of Neurology, Oslo University Hospital, Oslo, Norway.
Francesco RaimondiCell Networks, University of Heidelberg, Heidelberg, Germany.
Rob RussellCell Networks, University of Heidelberg, Heidelberg, Germany.
Peter LichtnerInstitute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Moinak BanerjeeRajiv Gandhi Centre for Biotechnology, Kerala, India.
Syam KrishnanSree Chitra Tirunal Institute for Medical Science and Technology, Kerala, India.
Roopa RajanSree Chitra Tirunal Institute for Medical Science and Technology, Kerala, India.
Divya Kalikavil PuthenveeduSree Chitra Tirunal Institute for Medical Science and Technology, Kerala, India.
Sun Ju ChungDepartment of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
International Parkinson's Disease Genomics Consortium (IPDGC)
Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease (COURAGE-PD)
Peter BauerInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Olaf RiessInstitute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
Christian Johannes GloecknerGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.ORCID 0000-0001-6494-6944
Rejko KrugerCenter of Neurology, and Hertie Institute for Clinical Brain Research, University Hospital, Tübingen, Germany.
Thomas GasserCenter of Neurology, and Hertie Institute for Clinical Brain Research, University Hospital, Tübingen, Germany.
Manu SharmaCentre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Germany.
University of Tübingen · DESree Chitra Thirunal Institute for Medical Sciences and Technology · INCentre Hospitalier de Luxembourg · LUGerman Center for Neurodegenerative Diseases · DEHeidelberg University · DEHelmholtz Zentrum München · DEHertie Institute for Clinical Brain Research · DEOslo University Hospital · NORajiv Gandhi Centre for Biotechnology · INUlsan College · KR

Funding

EU Joint Program-Neurodegenerative diseasesEuropean Union's Horizon2020 research and innovation program 692320German Research Council DFG; KR2119/8-1German Research Council DFG/SH 599/6-1Intramural NIH HHS Z99 AG999999Luxembourg National Research FundMichael J Fox FoundationMultiple System Atrophy Coalition, USANational Centre of Excellence in Research on Parkinson's diseasePEARL programme FNR; FNR/P13/6682797
6 · The paper itself

Abstract

backgroundGenetic variability in LRRK2 has been unequivocally established as a major risk factor for familial and sporadic forms of PD in ethnically diverse populations.

objectivesTo resolve the role of LRRK2 in the Indian population.

methodsWe performed targeted resequencing of the LRRK2 locus in 288 cases and 298 controls and resolved the haplotypic structure of LRRK2 in a combined cohort of 800 cases and 402 controls in the Indian population. We assessed the frequency of novel missense variants in the white and East Asian population by leveraging exome sequencing and densely genotype data, respectively. We did computational modeling and biochemical approach to infer the potential role of novel variants impacting the LRRK2 protein function. Finally, we assessed the phosphorylation activity of identified novel coding variants in the LRRK2 gene.

resultsWe identified four novel missense variants with frequency ranging from 0.0008% to 0.002% specific for the Indian population, encompassing armadillo and kinase domains of the LRRK2 protein. A common genetic variability within LRRK2 may contribute to increased risk, but it was nonsignificant after correcting for multiple testing, because of small cohort size. The computational modeling showed destabilizing effect on the LRRK2 function. In comparison to the wild-type, the kinase domain variant showed 4-fold increase in the kinase activity.

conclusionsOur study, for the first time, identified novel missense variants for LRRK2, specific for the Indian population, and showed that a novel missense variant in the kinase domain modifies kinase activity in vitro. © 2018 International Parkinson and Movement Disorder Society.

Indexed as

Genetic Predisposition to DiseaseGenetic VariationPolymorphism, Single NucleotideAdultAgedAged, 80 and overAllelesFemaleGene FrequencyGenotypeHaplotypesHumansIndiaLeucine-Rich Repeat Serine-Threonine Protein Kinase-2MaleMiddle AgedLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2neurodegenerationParkinson's disease

Identifiers

PMID30485545
PMCPMC8985845
OpenAlexW2903559376

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.